Matches in Nanopublications for { ?s ?p "[This mechanism also applies to hematopoietic cells transformed by other HOX genes, including CDX2, which is highly expressed in a majority of acute myeloid leukemias, thus providing a molecular approach based on GSK-3 inhibitory strategies to target HOX-associated transcription in a broad spectrum of leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP330071.RAYh1wwZAqZfebXIt0ODkCQSrEDrFna4WOXh_AhyXDTaw130_assertion description "[This mechanism also applies to hematopoietic cells transformed by other HOX genes, including CDX2, which is highly expressed in a majority of acute myeloid leukemias, thus providing a molecular approach based on GSK-3 inhibitory strategies to target HOX-associated transcription in a broad spectrum of leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330071.RAYh1wwZAqZfebXIt0ODkCQSrEDrFna4WOXh_AhyXDTaw130_provenance.
- NP308720.RAXwc0T84Qt7PgyCYC7RhuBhhkesKf9qrydtMSmHrzbfY130_assertion description "[This mechanism also applies to hematopoietic cells transformed by other HOX genes, including CDX2, which is highly expressed in a majority of acute myeloid leukemias, thus providing a molecular approach based on GSK-3 inhibitory strategies to target HOX-associated transcription in a broad spectrum of leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308720.RAXwc0T84Qt7PgyCYC7RhuBhhkesKf9qrydtMSmHrzbfY130_provenance.
- NP308706.RAmaiLnohBBRO7Z_PoqdT7qbEdW-z7DJFkSexST5FgQ9Q130_assertion description "[This mechanism also applies to hematopoietic cells transformed by other HOX genes, including CDX2, which is highly expressed in a majority of acute myeloid leukemias, thus providing a molecular approach based on GSK-3 inhibitory strategies to target HOX-associated transcription in a broad spectrum of leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308706.RAmaiLnohBBRO7Z_PoqdT7qbEdW-z7DJFkSexST5FgQ9Q130_provenance.
- NP818224.RAU0iBU8Xv3fXUMUrfv2SfwI4EDHemeQ46sI1z0PeGCzc130_assertion description "[This mechanism also applies to hematopoietic cells transformed by other HOX genes, including CDX2, which is highly expressed in a majority of acute myeloid leukemias, thus providing a molecular approach based on GSK-3 inhibitory strategies to target HOX-associated transcription in a broad spectrum of leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818224.RAU0iBU8Xv3fXUMUrfv2SfwI4EDHemeQ46sI1z0PeGCzc130_provenance.
- NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_assertion description "[This mechanism also applies to hematopoietic cells transformed by other HOX genes, including CDX2, which is highly expressed in a majority of acute myeloid leukemias, thus providing a molecular approach based on GSK-3 inhibitory strategies to target HOX-associated transcription in a broad spectrum of leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_provenance.
- NP818226.RA68mhs-jWbfzs91WvEutVCmvFhMgaPOQke_bdkRimIi0130_assertion description "[This mechanism also applies to hematopoietic cells transformed by other HOX genes, including CDX2, which is highly expressed in a majority of acute myeloid leukemias, thus providing a molecular approach based on GSK-3 inhibitory strategies to target HOX-associated transcription in a broad spectrum of leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818226.RA68mhs-jWbfzs91WvEutVCmvFhMgaPOQke_bdkRimIi0130_provenance.